World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   1118 records for 217 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
AuthorisedEUCTR2015-004026-34-HU
A study Comparing SB8 to Avastin in Subjects with Lung Cancer (Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer)
19/02/2016
RecruitingNCT02699736
Clinical and Virological Outcome of European Patients Infected With HIV
19/01/2016
AuthorisedEUCTR2015-003372-73-HU
A clinical trial to evaluate the safety and efficacy of ZTI-01 versus Piperacillin/Tazobactam in hospitalized patients with complicated urinary tract infections. 29/12/2015
RecruitingISRCTN14037475
Alcohol e-Help self-help intervention
13/11/2015
AuthorisedEUCTR2015-003334-27-SK
A Study to Compare ABT-494 Monotherapy to Methotrexate Monotherapy in Subjects with Rheumatoid Arthritis (RA) Who have not Previously taken Methotrexate (SELECT-EARLY) 04/11/2015
AuthorisedEUCTR2015-003332-13-SK
A Study Comparing ABT-494 to Placebo in Subjects with Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who have an Inadequate Response to csDMARDs Alone (SELECT-NEXT) 04/11/2015
AuthorisedEUCTR2015-003333-95-SK
A Study Comparing ABT-494 to Placebo and to Adalimumab in Subjects with Rheumatoid Arthritis who are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate (SELECT-COMPARE) 04/11/2015
RecruitingNCT02596321
A Study Investigating the Immunologic Effects and Safety of 60-day Treatment of the ALK-Abello A/S, Originator or ALK HDM Tablets in Adult Subjects With Allergic Rhinitis and/or Atopic Asthma Induced by House Dust Mites (HDM)
02/11/2015
AuthorisedEUCTR2015-000717-40-GB
A research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-000717-40-LTA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.19/11/2015
AuthorisedEUCTR2015-000717-40-ESA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.10/12/2015
AuthorisedEUCTR2015-000717-40-DEA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.27/10/2015
AuthorisedEUCTR2015-000717-40-CZA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.23/10/2015
AuthorisedEUCTR2015-000717-40-SKA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.27/10/2015
Not recruitingNCT02676089TRIple in Asthma hiGh strenGth vErsus Ics/Laba hs and tiotRopium (TRIGGER)03/02/2016
AuthorisedEUCTR2015-000717-40-PLA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.21/12/2015
AuthorisedEUCTR2015-000717-40-HUA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at high dose in patients with uncontrolled asthma.11/11/2015
05/10/2015
AuthorisedEUCTR2015-000716-18-GB
A research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2015-000716-18-LTA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.19/11/2015
AuthorisedEUCTR2015-000716-18-CZA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.07/10/2015
AuthorisedEUCTR2015-000716-18-PTA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.22/10/2015
AuthorisedEUCTR2015-000716-18-SKA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.27/10/2015
Not recruitingNCT02676076TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA03/02/2016
AuthorisedEUCTR2015-000716-18-ESA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.10/12/2015
AuthorisedEUCTR2015-000716-18-HUA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.29/10/2015
AuthorisedEUCTR2015-000716-18-PLA research study to evaluate the effect of a new fixed triple combination of beclometasone dipropionate + formoterol fumarate + glycopyrronium bromide at medium dose in patients with uncontrolled asthma.22/12/2015
05/10/2015
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history